Dr. Patricia Bloom is an Assistant Professor and transplant hepatologist at the Mayo Clinic. She performs clinical and translational research to improve outcomes in decompensated cirrhosis, especially for hepatic encephalopathy. Her goals are to create and test innovative microbiome therapies to treat hepatic encephalopathy and other cirrhosis complications. She is also developing innovative technology solutions for the management of decompensated cirrhosis. She serves as an Associate Editor for Hepatology Communications and on the Mentorship and Membership Committee of AASLD.

Associate Professor<br>Division of Gastroenterology and Hepatology<br>Department of Internal Medicine<br>Kangbuk Samsung Hospital<br>Sungkyunkwan University School of Medicine

Chaowapong (Chao) Jarasvaraparn, MD graduated from Medical School at Mahidol University in Bangkok, Thailand. He completed his Pediatric Residency training at the University of South Alabama in Mobile, Alabama. He completed Pediatric Gastroenterology Fellowship Program and Transplant Hepatology at Washington University School of Medicine in St. Louis. Currently he is a pediatric hepatologist at Riley Hospital for Children, Indiana University. His research interests include pediatric MASLD, pediatric liver transplantation and Fontan-associated liver disease.  

I received my PhD degree in Cell and Molecular Biology from Paris-Est University in France in 2014. I accomplished my postdoctoral training at Mayo Clinic in 2020. Since then, I am an Assistant Professor at Mayo Clinic where I study the biology of hepatic stellate cells.

Denisse Rubio Cruz, MD is a Postdoctoral Research Fellow in Hepatology at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, MA. She received her medical degree from Universidad de los Andes in Colombia. Under the mentorship of Z. Gordon Jiang MD, PhD, she conducts translational liver research on ex vivo tissues, using the human precision-cut liver slice (PCLS) model. Her study is focused on cellular dynamic changes and inherent plasticity of liver tissues for understanding human disease.

Hello, I'm a hepatologist from South Korea. My main interests include alcohol-related cirrhosis, portal hypertension, metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma. I'm particularly interested in bridging clinical care with research to improve outcomes in chronic liver disease.

Gastroenterology Fellow with a strong focus on everything liver-related

Lamia Haque, MD, MPH is an Assistant Professor of Medicine at Yale School of Medicine in the Section of Digestive Diseases, Core Faculty in the Yale Program in Addiction Medicine, Director of the Yale Clinic for Alcohol and Addiction Treatment in Hepatology, and early career clinician-investigator supported a K23 Career Development Award through the NIAAA on integrated care for alcohol-associated liver disease and alcohol use disorder in hepatology clinics.

Dr. Erin Cleveland is an assistant professor of gastroenterology and hepatology at the University of Washington, where she serves as the medical director of the Harborview Medical Center Hepatitis & Liver Clinic. Dr. Cleveland serves as a panelist for the University of Washington Project ECHO, mentoring clinicians treating viral hepatitis in underserved and rural areas of the Pacific Northwest. Her clinical interests include alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease, and palliative care interventions in advanced liver disease.